Lion Point Capital »

Mersana Therapeutics shares owned by Lion Point Capital

Quarter-by-quarter ownership of Mersana Therapeutics (MRSN) shares owned by Lion Point Capital from 13F filings

Historical chart of Lion Point Capital investment in Mersana Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mersana Therapeutics held by Lion Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mersana Therapeutics by Lion Point Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $200k 26k 7.76

More positions owned by Lion Point Capital

Mineralys Therapeutics (MLYS)
Milestone Pharmaceuticals (MIST)
Fennec Pharmaceuticals (FENC)
Jasper Therapeutics Com New (JSPR)
Avadel Pharmaceuticals Com Shs (AVDL)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Insmed Com Par $.01 (INSM)
Ardelyx (ARDX)
Benitec Biopharma Com New (BNTC)
Syndax Pharmaceuticals (SNDX)
Royalty Pharma Shs Class A (RPRX)
Disc Medicine (IRON)
Bridgebio Pharma (BBIO)
Geron Corporation (GERN)
Arcutis Biotherapeutics (ARQT)

View all positions for Lion Point Capital

Top funds holding Mersana Therapeutics

Nextech Invest
Alamea Verwaltungs GmbH
Bain Capital Life Sciences Investors
Vanguard Group
Schonfeld Strategic Advisors
Rock Springs Capital Management
Acadian Asset Management
Silverarc Capital Management
683 Capital Management
BlackRock
Renaissance Technologies
Millennium Management
5AM Venture Management
Mackenzie Financial
AQR Capital Management

View all funds holding Mersana Therapeutics